Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial

Autor: Maryam Nasimi, S. Ghale-Baghi, Arghavan Azizpour, Kamran Balighi, Seyedeh Zahra Ghodsi, Maryam Daneshpazhooh

Publikováno v: International Journal of Women's Dermatology, Vol 3, Iss 2, Pp 107-110 (2017)
International Journal of Women's Dermatology

Background: Seborrheic dermatitis (SD) is a chronic dermatitis with periods of remission and relapse that requires long-term treatment. Objective: We compared the efficacy and safety of treatment with sertaconazole with standard corticosteroid medica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::525325a57d679bab9ab8568aeab1871c
http://www.sciencedirect.com/science/article/pii/S235264751630034X

Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial.

Autor: Balighi K; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Ghodsi SZ; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Daneshpazhooh M; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Ghale-Baghi S; Research Center and Department of Head and Neck Surgery, Hazrat-e-Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran., Nasimi M; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Azizpour A; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: International journal of women's dermatology [Int J Womens Dermatol] 2016 Dec 23; Vol. 3 (2), pp. 107-110. Date of Electronic Publication: 2016 Dec 23 (Print Publication: 2017).